Quick Answer
Cardiol Therapeutics Inc. reported Total Assets of $36.70 million for fiscal year 2023.
Cardiol Therapeutics Inc. — Key Financials by Year
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Total Assets | $36.70M -40.8% |
$62.03M -29.4% |
$87.88M | — |
| R&D Expense | $14.22M -25.0% |
$18.96M +74.4% |
$10.87M +2.5% |
$10.60M |
- Cardiol Therapeutics Inc. reported Total Assets of $36.70 million for fiscal year 2023.
- Cardiol Therapeutics Inc. showed a decrease of -40.8% in Total Assets compared to the prior fiscal year.
- Cardiol Therapeutics Inc. reported R&D Expense of $14.22 million for fiscal year 2023.
- Cardiol Therapeutics Inc. showed a decrease of -25.0% in R&D Expense compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: